Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy

Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy

Booth, L., Adams, R., Clifford, A., Aguilar, F., Ali, N., Bishop, C., Sufi, J., Wu, Y., Fitzpartick, A., Geh, J. L. C., MacKenzie Ross, A. D., Lloyd-Hughes, H., Stodell, M., Daniel, C. S., Whittaker, S., Sinha, K., Willsmore, Z. N., Terranova-Barberio, M., Ali, N. & Lacy, K. E. & 3 others, Tull, T. J., Tsoka, S. & Karagiannis, S. N., 7 Aug 2026, In: Journal for ImmunoTherapy of Cancer. 14, 8

Research output: Contribution to journal › Article › peer-review